29^th World Conference on Gastroenterology & Hepatology August 23-24, 2023 Toronto, Canada

Dr. Winter is Clinical Associate Professor of Medicine in the Division of Gastroenterology and Hepatology, at Stanford School of Medicine, Stanford, California, USA. He is Board Certified in Internal Medicine and Gastroenterology, and has specific interest in the management and treatment of intestinal failure, nutrition rehabilitation and inflammatory bowel disease. He completed fellowship training at Groote Schuur Hospital in Cape Town, South Africa, and at the John Radcliff Hospital OX, UK. He accomplished his PhD (Medicine) at the University of Cape Town. He is the author of 62 papers, editorials, letters and reviews, 9 chapters, and 84 abstracts.

Associate Professor Stanford University, USA Tel: 650-724-4509 Fax: 650-498-5174

Prof. Chris Constantinou has a formal education in biomedical engineering at Stanford University, USA and was fortunate to be appointed to the clinical Department of Urology, Stanford Medical School for all of his professional life. Prof. Constantinou looks forward to developing links with groups interested in imaging technology particularly using ultrasound to address basic and clinical problems quantitatively.

1.Pharmacologic methods in identifying alpha adrenergic receptors in the obstructed urinary tract. 2. Fluid mechanics and physiological mechanisms of contractility in the urinary tract. 3. Biomedical Engineering approaches in the characterization of static and dynamic properties of soft tissues 4. Image processing and 3D reconstruction of magnetic resonance 5. Computer models and vector analysis of pelvic floor musculature 6. Software for interactive teaching

Min Li got his Ph.D. from Emory University at Atlanta, Georgia in 2002, under the supervision of Dr. Richard W. Compans, a world renowned virologist and immunologist. Li studied the regulation of a retrovirus envelope protein induced membrane fusion and the association with lipid rafts. He then moved on to Baylor College of Medicine at Houston, Texas, USA and started his career in cancer research as an Assistant Professor in 2004. Li joined the University of Texas Health Science Center at Houston, Medical School in 2010 as the Director of Cancer Research Program. His research interests include pancreatic cancer and brain tumor pathogenesis, translational research, new therapies and tumor vaccine development. Li′s group is the first one to identify a zinc transporter (ZIP4) as a new molecular target in pancreatic cancer, and has developed a novel therapy to treat this malignancy.

Pancreatic cancer and brain tumor pathogenesis. Translational research, new therapies (shRNA therapy, small molecule therapy, and nutrition/diet therapy), and tumor vaccine development.

Maxwell M Chait completed his MD degree at the age of 25 from the University of California School of Medicine at San Francisco. He is a Fellow of several prestigious organizations, including the American College of Physicians, American College of Gastroenterology, American Gastroenterological Association and the American Society for Gastrointestinal Endoscopy. He is a practicing gastroenterologist on the faculty of the Columbia University College of Physicians and Surgeons. He has authored more than 40 publications in reputed journals. He is the editor-in-chief of the Journal of Liver Disease and Transplantation and serves on the editorial board of the World Journal of Gastrointestinal Endoscopy.

Columbia College of Physicians and Surgeons, USA

Amr Amin is a Professor of Cell & Molecular Biology and a graduate faculty at UAE University. He earned his PhD in Cell & Developmental Biology from University of Illinois at Chicago and received a postdoctoral training in Molecular Genetics at University of Pennsylvania School of Medicine. After joining UAEU, Dr. Amin’s focus was redirected to the field of preventive medicine. His lab is interested in natural product-based protection against cancer. Most recently, his lab has been employing non-invasive approaches and nanoparticles to learn more about the molecular aspects of chemoprevention particularly against liver cancer. He published many research articles, reviews and book chapters in reputable journals. He also serves on the editorial boards and as a reviewer of many international journals. Dr. Amin is also the recipient of many national and international awards.

Amr Amin research interests focus biology and chemoprevention of cancer, preclinical studies, and novel plant-based anticancer drugs.

Pankaj Kumar Singh completed his Ph.D at the age of 26 years. He completed his postdoctoral studies from Salk Institute for Biological Studies, San Diego, California. He is currently an associate professor at Eppley Institute For Cancer Research, University of Nebraska Medical Center, Omaha, Nebraska. He has published several articles in reputed journals, including PNAS and Nature, and has obtained several national awards.

Pankaj Kumar Singh research is focused on metabolic alterations in tumors and he is utilizing metabolomic tools to investigate the mechanisms of chemoresistance in pancreatic cancer.